US Patent Issued to I2O Therapeutics on Feb. 3 for "Human amylin analog polypeptides and methods of use" (Massachusetts Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,168, issued on Feb. 3, was assigned to I2O Therapeutics Inc. (Cambridge, Mass.).

"Human amylin analog polypeptides and methods of use" was invented by William Blackwell (Cambridge, Mass.), Ved P. Srivastava (Cambridge, Mass.) and James M. Way (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to isolated polypeptides that are analogs of human amylin. The disclosed amylin analog polypeptides have beneficial physicochemical properties relative to endogenous amylin, such as longer elimination half-lives (t1/2) and improved solubility and thermal stability. This invention also relates to methods of using presently dis...